Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine and Animal Resources, King Faisal University, PO Box 400, Al-Ahsa, 31982, Saudi Arabia
*Email: malnazawi@kfu.edu.sa
Online published on 26 May, 2015.
Administration of enrofloxacin at a dose of 5 mg/kg intramuscularly for 3 days has resulted in a significant decrease in aminopyrine-N-demathylase and aniline-4-hydroxylase in liver of camel compared to saline treated (controls). It is suggested that co-administration of drugs metabolised by phase-I reaction with enrofloxacin should be avoided in camels.
Camel, enrofloxacin, hepatic, oxidases
